120 related articles for article (PubMed ID: 7106955)
1. Motor and sensory conduction in peripheral nerves of unanaesthetized streptozotocin diabetic and normal rats during ischemia.
David J; Wagle GP; Grewal RS
Indian J Physiol Pharmacol; 1982; 26(1):13-22. PubMed ID: 7106955
[TBL] [Abstract][Full Text] [Related]
2. Resistance to ischemic conduction block of the peripheral nerve in hyperglycemic rats: an electrophysiological study.
Shirabe S; Kinoshita I; Matsuo H; Takashima H; Nakamura T; Tsujihata M; Nagataki S
Muscle Nerve; 1988 Jun; 11(6):582-7. PubMed ID: 3386666
[TBL] [Abstract][Full Text] [Related]
3. Aminoguanidine--effects on endoneurial vasoactive nitric oxide and on motor nerve conduction velocity in control and streptozotocin-diabetic rats.
Dewhurst M; Omawari N; Tomlinson DR
Br J Pharmacol; 1997 Feb; 120(4):593-8. PubMed ID: 9051296
[TBL] [Abstract][Full Text] [Related]
4. Ischemia-reperfusion injury of peripheral nerve in experimental diabetic neuropathy.
Wang Y; Schmelzer JD; Schmeichel A; Iida H; Low PA
J Neurol Sci; 2004 Dec; 227(1):101-7. PubMed ID: 15546599
[TBL] [Abstract][Full Text] [Related]
5. Distal neuropathy in experimental diabetes mellitus.
Brown MJ; Sumner AJ; Greene DA; Diamond SM; Asbury AK
Ann Neurol; 1980 Aug; 8(2):168-78. PubMed ID: 7425570
[TBL] [Abstract][Full Text] [Related]
6. Prolonged ischemic conduction failure after reperfusion in diabetic nerve.
Baba M; Nukada H; McMorran D; Takahashi K; Wada R; Yagihashi S
Muscle Nerve; 2006 Mar; 33(3):350-5. PubMed ID: 16320311
[TBL] [Abstract][Full Text] [Related]
7. The INFIR Cohort Study: assessment of sensory and motor neuropathy in leprosy at baseline.
Van Brakel WH; Nicholls PG; Das L; Barkataki P; Maddali P; Lockwood DN; Wilder-Smith E
Lepr Rev; 2005 Dec; 76(4):277-95. PubMed ID: 16411508
[TBL] [Abstract][Full Text] [Related]
8. Nerve conduction changes and fine structural alterations of extra- and intrafusal muscle and nerve fibers in streptozotocin diabetic rats.
Weis J; Dimpfel W; Schröder JM
Muscle Nerve; 1995 Feb; 18(2):175-84. PubMed ID: 7823975
[TBL] [Abstract][Full Text] [Related]
9. The neurocytokine, interleukin-6, corrects nerve dysfunction in experimental diabetes.
Cameron NE; Cotter MA
Exp Neurol; 2007 Sep; 207(1):23-9. PubMed ID: 17560573
[TBL] [Abstract][Full Text] [Related]
10. Aldose reductase-deficient mice are protected from delayed motor nerve conduction velocity, increased c-Jun NH2-terminal kinase activation, depletion of reduced glutathione, increased superoxide accumulation, and DNA damage.
Ho EC; Lam KS; Chen YS; Yip JC; Arvindakshan M; Yamagishi S; Yagihashi S; Oates PJ; Ellery CA; Chung SS; Chung SK
Diabetes; 2006 Jul; 55(7):1946-53. PubMed ID: 16804062
[TBL] [Abstract][Full Text] [Related]
11. Effect of cerivastatin on peripheral capillary permeability to albumin and peripheral nerve function in diabetic rats.
Cohen-Boulakia FE; Tarhzaoui K; Valensi PE; Lestrade RA; Albertini JP; Behar A
Diabetes Metab; 2007 Jun; 33(3):189-96. PubMed ID: 17379559
[TBL] [Abstract][Full Text] [Related]
12. Effect of propionyl-L-carnitine on motor nerve conduction, autonomic cardiac function, and nerve blood flow in rats with streptozotocin-induced diabetes: comparison with an aldose reductase inhibitor.
Hotta N; Koh N; Sakakibara F; Nakamura J; Hamada Y; Wakao T; Hara T; Mori K; Naruse K; Nakashima E; Sakamoto N
J Pharmacol Exp Ther; 1996 Jan; 276(1):49-55. PubMed ID: 8558455
[TBL] [Abstract][Full Text] [Related]
13. Effects of trolox on nerve dysfunction, thermal hyperalgesia and oxidative stress in experimental diabetic neuropathy.
Sharma SS; Sayyed SG
Clin Exp Pharmacol Physiol; 2006 Nov; 33(11):1022-8. PubMed ID: 17042909
[TBL] [Abstract][Full Text] [Related]
14. [Comparison between Dyck's criteria and the polyneuropathy index-revised (PNI-R) in the electrophysiologic evaluation of diabetic neuropathy].
Hasegawa O; Matsumoto S; Gondo G; Wada N; Arita T
No To Shinkei; 2001 Nov; 53(11):1015-9. PubMed ID: 11761909
[TBL] [Abstract][Full Text] [Related]
15. Motor and sensory nerve conduction velocities in Yucatan minipigs.
Hort-Legrand C; Noah L; Mériguet E; Mésangeau D
Lab Anim; 2006 Jan; 40(1):53-7. PubMed ID: 16460588
[TBL] [Abstract][Full Text] [Related]
16. Independent alterations in the central and peripheral somatosensory pathways in rat diabetic neuropathy.
Piriz J; Torres-Aleman I; Nuñez A
Neuroscience; 2009 May; 160(2):402-11. PubMed ID: 19264110
[TBL] [Abstract][Full Text] [Related]
17. Depletion of taurine in experimental diabetic neuropathy: implications for nerve metabolic, vascular, and functional deficits.
Pop-Busui R; Sullivan KA; Van Huysen C; Bayer L; Cao X; Towns R; Stevens MJ
Exp Neurol; 2001 Apr; 168(2):259-72. PubMed ID: 11259114
[TBL] [Abstract][Full Text] [Related]
18. Comparison of short-term effects of insulin and essential fatty acids on the slowed nerve conduction of streptozotocin diabetes in rats.
Julu PO; Mutamba A
J Neurol Sci; 1991 Nov; 106(1):56-9. PubMed ID: 1663993
[TBL] [Abstract][Full Text] [Related]
19. Effect of age on sensory nerve conduction velocity in the horse.
Wheeler SJ
Res Vet Sci; 1990 Mar; 48(2):141-4. PubMed ID: 2333419
[TBL] [Abstract][Full Text] [Related]
20. Hypoxic neuropathy versus diabetic neuropathy. An electrophysiological study in rats.
Hendriksen PH; Oey PL; Wieneke GH; van Huffelen AC; Gispen WH
J Neurol Sci; 1992 Jul; 110(1-2):99-106. PubMed ID: 1506876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
